Takeda Gets EC Nod To Acquire Swiss Drug Maker Nycomed
This article was originally published in PharmAsia News
Executive Summary
Takeda Pharmaceutical's acquisition of Switzerland's Nycomed received European Commission clearance based on a judgment the merged firm would still have competition